Did Obray slip away after hit job by HB?
EXHIBIT A
ARTICLES OF MERGER
[To be completed]
RMT DISCLOSURE SCHEDULE
Schedule 3.7Personal Property
•Data License Agreement dated May _, 2018 between Southwest Spine and Pain Care Specialists, LLC and Regenerative Medical Technologies, Inc.
•Draft Provisional Patent Application -Systems and Methods for Linking and Storing Biologics.
•Cellsure business model, methods and protocols to collect birthing tissue, DNA samples and electronic medical records online or on mobile app.
•Patient Registry business model, methods and protocols to collect clinical outcomes and electronic medical records online or on mobile app.
•DNA sample business model, methods and protocols to collect DNA samples and electronic medical records online or on mobile app.
•Bone Marrow Aspirate Kit - draft product design and methodology.
•Large Joint Injection Kit-draft product design and methodology.
•Degenerative Disk Disease (DDD) and Post-Microdiscectomy Injection Kit - draft product design and methodology.
•Allogenic Stem Cell Product for DOD-draft product design and preliminary clinical trial methodology
•Allogenic Stem Cell Product for Autism and CP - draft product design and preliminary clinical trial methodology
•Allogenic Stem Cell Product for Facet Joint - draft product design and preliminary clinical trial methodology
26
•Allogenic Stem Cell Product for IV Treatment of Opioid Addiction - draft product design and preliminary clinical trial methodology
•Clinical Trial protocol know-how (draft design for knee arthritis, trochanteric bursitis, plantar fasciitis, discogenic back pain, facet joint pain).
Schedule 3.13 Contractual and Other Obligations
•See Schedule 3.7 above.
Schedule 4.4
There are no pending or threatened actions except for:
(i)a lawsuit filed by Robert Greeen, Troy Menlove and TRJ, LLC in the Third Judicial District Court against Jack Turner, Buyer and Predictive Biotech, Inc. in July 2018 alleging, among other things, that cash and stock compensation is due to plaintiffs and Buyer disputes such claims; and
(ii)there is a dispute between Buyer and Mike Schramm, Buyer's former patent agent, whereby Mr. Schramm alleges he is owed common stock as compensation for intellectual property transferred to Buyer and/or its affiliates and for work performed. Buyer believes Mr. Schramm has been fully compensated for all transferred intellectual property and work performed.
